The U.S. Food and Drug Administration approved a supplemental New Drug Application for Shionogi & Co. Ltd.’s Fetroja (cefiderocol) for the treatment of patients 18 years of age or older with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP).
A rheumatoid arthritis drug developed by Genentech proved to be effective in benefitting patients who have Covid-19-associated pneumonia, according to new late-stage clinical trial data.
First Covid-19 reinfection case reported; low oxygen levels linked to widening blood vessels in lungs
Blood Vessels, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Reinfections, Coronavirus Mutations, Covid-19 Pneumonia, Genetics, Hong Kong, Lungs, Oxygen, Researchers, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)A roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19, the illness caused by the virus.
Covid-19 patients with pneumonia improved faster when treated with Vanda Pharmaceuticals Inc.’s experimental therapy than those on placebo, the company said, citing an interim analysis of data from a late-stage study.
Merck’s investigational pneumonia vaccine V114 hit the mark in two Phase III studies, including one involving adult HIV patients.
Roche and Gilead Sciences launched a Phase III clinical trial in severe COVID-19 pneumonia, testing Roche’s Actemra/RoActemra with Gilead’s remdesivir.
COVID patients given malaria drug didn’t see significant improvements: studies
Antimalarial, China, Clinical Data, Clinical Trials, Coronavirus Disease 2019 (COVID-19), Donald Trump, FDA, Hydroxychloroquine, Medical Journals, National Institutes of Health, Patients, Placebo, Pneumonia, R&D, Studies, The BMJPatients given the malaria drug touted by President Donald Trump as a potential treatment for COVID-19 did not improve significantly over those who did not, according to two new studies published in the medical journal BMJ .
GlaxoSmithKline started a trial to test an experimental rheumatoid arthritis drug on patients suffering from COVID-19 related pneumonia.
Italian researchers are looking at whether a higher than usual number of cases of severe pneumonia and flu in Lombardy in the last quarter of 2019 may be a signal that the new coronavirus might have spread beyond China earlier than previously thought.
Days after Roche began shipping hundreds of thousands of the Swiss pharma giant’s recently approved COVID-19 test to laboratories in the United States, the company initiated a late-stage trial assessing the rheumatoid arthritis drug Actemra in patients who have severe COVID-19 caused pneumonia.